CDK4/6 Inhibitors in Metastatic HR-Positive Breast Cancer

NCT07704801 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Breast Cancer

Interventions

DRUG: CDK4/6 inhibitors

Sponsor

Sohag University